(Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | (FY)Jan 28, 2023 | (Q4)Jan 28, 2023 | (Q3)Oct 29, 2022 | (Q2)Jul 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 3.21%-8.23M | 32.07%38.7M | 7.05%44.19M | 322.42%4.05M | 76.47%-1.04M | -47.68%-8.51M | -48.11%29.3M | -23.75%41.28M | -123.98%-1.82M | -216.76%-4.4M |
Net income from continuing operations | -11.66%-8.9M | -72.51%1.84M | 12.64%14.62M | -76.51%519K | -64.88%-5.33M | -51.42%-7.97M | -70.60%6.69M | -28.33%12.98M | -79.48%2.21M | -175.09%-3.24M |
Depreciation and amortization | -3.93%7.24M | 1.30%29.71M | -2.30%7.46M | 0.66%7.36M | 2.20%7.35M | 4.90%7.54M | -2.23%29.32M | 3.31%7.64M | -1.83%7.31M | -5.84%7.19M |
Asset impairment expenditure | ---- | -85.98%61K | ---- | ---- | ---- | ---- | -32.97%435K | ---- | ---- | ---- |
Remuneration paid in stock | -9.00%91K | 19.47%454K | 520.69%122K | 2.06%99K | 18.75%133K | -50.00%100K | -41.98%380K | -231.82%-29K | -63.40%97K | -62.03%112K |
Deferred tax | -10.08%-3.11M | -71.92%815K | 8.92%5.25M | -74.46%259K | -66.61%-1.87M | -56.07%-2.83M | -65.60%2.9M | -26.21%4.82M | -74.45%1.01M | -250.00%-1.12M |
Other non cashItems | -6.26%2.13M | -8.16%7.14M | -94.68%118K | 16.00%2.55M | 58.75%2.21M | 15.12%2.27M | 34.70%7.78M | 22.94%2.22M | 102.58%2.2M | 76.72%1.39M |
Change In working capital | 45.17%-3.66M | 226.10%6.74M | 19.95%19.07M | 61.84%-4.2M | 73.14%-1.44M | -37.77%-6.68M | -280.64%-5.35M | -39.51%15.9M | 17.19%-11.02M | -584.97%-5.38M |
-Change in receivables | -35.72%1.85M | -141.80%-390K | -113.39%-279K | 3,651.52%1.17M | 4.30%-4.16M | -10.93%2.88M | -21.00%933K | -47.94%2.08M | -122.00%-33K | -75.25%-4.35M |
-Change in inventory | -83.36%760K | 237.13%18.83M | 41.19%25.22M | 69.50%-5.51M | 65.05%-5.45M | 122.18%4.57M | -1,299.48%-13.73M | -27.65%17.87M | 2.05%-18.07M | -211.22%-15.58M |
-Change in prepaid assets | 6.77%-1.38M | -447.08%-1.9M | -121.45%-335K | 63.25%-197K | 112.03%108K | -451.90%-1.48M | 165.87%548K | 285.95%1.56M | -200.75%-536K | -40.31%-898K |
-Change in payables and accrued expense | 62.39%-4.64M | -225.79%-9.05M | 7.88%-5.73M | -94.00%471K | -46.35%8.54M | -19.20%-12.34M | 712.30%7.2M | -107.37%-6.22M | 64.01%7.85M | 110.60%15.92M |
-Change in other working capital | 17.95%-256K | -158.82%-748K | -69.21%186K | 37.73%-137K | -3.85%-485K | -51.46%-312K | -149.91%-289K | -57.58%604K | 30.60%-220K | -116.20%-467K |
Interest paid (cash flow from operating activities) | 5.94%-2.01M | -9.65%-8.99M | -1.97%-2.22M | -9.04%-2.44M | -13.01%-2.19M | -15.93%-2.14M | 0.32%-8.2M | -14.38%-2.18M | -6.13%-2.23M | 8.24%-1.94M |
Tax refund paid | -100.58%-7K | 119.73%922K | 41.88%-290K | 99.86%-2K | 100.70%10K | 189.38%1.2M | 27.34%-4.67M | 89.49%-499K | -161.87%-1.4M | -157.58%-1.43M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 3.21%-8.23M | 32.07%38.7M | 7.05%44.19M | 327.80%4.15M | 74.24%-1.13M | -47.68%-8.51M | -48.11%29.3M | -23.75%41.28M | -123.98%-1.82M | -216.76%-4.4M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -30.43%-1.87M | 19.12%-5.13M | 10.08%-1.51M | 51.26%-928K | 24.87%-1.27M | -32.32%-1.43M | -44.01%-6.35M | -43.62%-1.68M | -44.57%-1.9M | -37.10%-1.69M |
Net PPE purchase and sale | -64.96%-1.87M | 24.50%-4.79M | 12.53%-1.47M | 51.26%-928K | 24.87%-1.27M | -4.62%-1.13M | -44.01%-6.35M | -43.62%-1.68M | -44.57%-1.9M | -37.10%-1.69M |
Net intangibles purchas and sale | ---- | ---41K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net other investing changes | ---- | ---300K | --0 | --0 | --0 | ---300K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -30.43%-1.87M | 19.12%-5.13M | 10.08%-1.51M | 51.26%-928K | 24.87%-1.27M | -32.32%-1.43M | -44.01%-6.35M | -43.62%-1.68M | -44.57%-1.9M | -37.10%-1.69M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 31.12%-5.52M | -48.67%-37.45M | -88.33%-19.23M | -41.20%-3.21M | -21.32%-6.99M | -15.45%-8.01M | 6.92%-25.19M | 60.14%-10.21M | 71.00%-2.27M | -427.87%-5.76M |
Net issuance payments of debt | 9.33%-5.52M | -40.32%-32.63M | -102.40%-19.23M | -31.35%-2.99M | 24.93%-4.33M | -6.47%-6.09M | 8.81%-23.26M | 61.93%-9.5M | 70.96%-2.27M | -318.00%-5.76M |
Net common stock issuance | --0 | -109.36%-4.05M | --0 | ---219K | ---2.66M | 4.17%-1.17M | -207.80%-1.93M | -7.09%-710K | --0 | --0 |
Net other financing activities | ---- | ---768K | --0 | ---5K | ---10K | ---753K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 31.12%-5.52M | -48.67%-37.45M | -88.33%-19.23M | -41.20%-3.21M | -21.32%-6.99M | -15.45%-8.01M | 6.92%-25.19M | 60.14%-10.21M | 71.00%-2.27M | -427.87%-5.76M |
Net cash flow | ||||||||||
Beginning cash position | -12.18%28.03M | -6.56%31.92M | 81.19%4.59M | -46.31%4.58M | -31.44%13.97M | -6.56%31.92M | 272.69%34.16M | -62.86%2.53M | 1.75%8.53M | 399.14%20.38M |
Current changes in cash | 12.98%-15.62M | -73.57%-3.89M | -20.22%23.45M | 100.12%7K | 20.74%-9.39M | -30.24%-17.95M | -108.96%-2.24M | 7.47%29.39M | -282.77%-6M | -375.67%-11.85M |
End cash Position | -11.15%12.41M | -12.18%28.03M | -12.18%28.03M | 81.19%4.59M | -46.31%4.58M | -31.44%13.97M | -6.56%31.92M | -6.56%31.92M | -62.86%2.53M | 1.75%8.53M |
Free cash from | -4.80%-10.1M | 47.54%33.86M | 7.77%42.68M | 186.41%3.22M | 60.57%-2.4M | -40.87%-9.64M | -55.92%22.95M | -25.23%39.6M | -159.36%-3.72M | -339.55%-6.09M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.